 
<prompt> National-Level Trends in IPTp 1+ | Percent of women age 15-49 with a live birth in the past two years who, during their last pregnancy, received atleast 1 dose of SP/Fansidar during an antenatal care visit. | (EDSB-III 2006, 5) (EDSB-IV 2011-2012, 31) (EDSB-V 2017-2018, 49) <response> Nearly half of women age 15-49 who had a live birth in the two years before the survey (49%) received at least one dose of SP/Fansidar during an antenatal visit. Coverage of IPTp 1+ increased significantly from 5% in 2006 to 31% in 2011-2012 to 49% in 2017-2018  